Sysmex Inostics: OncoBEAM(TM) RAS CRC Liquid Biopsy Test Now Reimbursed in Germany by BARMER

HAMBURG, Germany, April 11, 2018 -- (Healthcare Sales & Marketing Network) -- Colorectal cancer patients in Germany insured by BARMER are now covered for the OncoBEAM RAS CRC IVD Test, an innovative liquid biopsy diagnostic that delivers a comprehensive e... Diagnostics, Oncology, Reimbursement Sysmex Inostics, OncoBEAM, RAS mutation, colorectal cancer, liquid biopsy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news